Center for Scientific Review; Notice of Meeting, 57399 [2013-22631]

Download as PDF Federal Register / Vol. 78, No. 181 / Wednesday, September 18, 2013 / Notices unable to attend in person, FDA will provide a Webcast to the meeting. Additional information about the Webcast location will be posted on the Web page, https://www.fda.gov/Drugs/ NewsEvents/ucm356526.htm, prior to December 4, 2013. Any person requiring special accommodations to attend the hearing should direct those needs to the contact persons (see Contact Persons) at least 7 days in advance. emcdonald on DSK67QTVN1PROD with NOTICES IV. Notice of Hearing Under 21 CFR Part 15 The Commissioner of Food and Drugs is announcing that the public hearing will be held in accordance with part 15 (21 CFR part 15). The hearing will be conducted by a presiding officer, who will be accompanied by FDA senior management from the Center for Drug Evaluation and Research. Under § 15.30(f), the hearing is informal and the rules of evidence do not apply. No participant may interrupt the presentation of another participant. Only the presiding officer and panel members may question any person during or at the conclusion of each presentation. Public hearings under part 15 are subject to FDA’s policy and procedures for electronic media coverage of FDA’s public administrative proceedings (21 CFR part 10, subpart C). Under 21 CFR 10.205, representatives of the electronic media may be permitted, subject to certain limitations, to videotape, film, or otherwise record FDA’s public administrative proceedings, including presentations by participants. The hearing will be transcribed as stipulated in § 15.30(b) (see section III of this document for more details). To the extent that the conditions for the hearing as described in this document conflict with any provisions set out in part 15, this notice acts as a waiver of those provisions as specified in § 15.30(h). V. Request for Comments Regardless of attendance at the public hearing, interested persons may submit either electronic comments to https:// www.regulations.gov or written comments to the Division of Dockets Management (see Comments). Persons who wish to provide additional materials for consideration should file these materials with the Division of Dockets Management by March 4, 2014. You should annotate and organize your comments to identify the specific questions identified by the topic to which they refer. It is only necessary to send one set of comments. All comment submissions should be marked with the docket number found in brackets in the VerDate Mar<15>2010 16:45 Sep 17, 2013 Jkt 229001 heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. VI. References The following references have been placed on display in the Division of Dockets Management (see Comments) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday, and are available electronically at https:// www.regulations.gov. 1. U.S. Environmental Protection Agency, ‘‘Health Effects Support Document for Acanthamoeba,’’ 2003. 2. Bowman, E. K., A. A. Vass, R. Mackowski, et al., ‘‘Quantitation of Free-Living Amoebae and Bacterial Populations in Eyewash Stations Relative to Flushing Frequency,’’ American Industrial Hygiene Association Journal, vol. 57, pp. 626–633, 1996. Dated: September 12, 2013. Leslie Kux, Assistant Commissioner for Policy. 57399 MSC 7776, Bethesda, MD 20892, (301) 435– 1111, schneidd@csr.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into NIH buildings. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/aboutcsr/ CSROrganization/Pages/CSRAC.aspx, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846– 93.878, 93.892, 93.893, National Institutes of Health, HHS) [FR Doc. 2013–22646 Filed 9–17–13; 8:45 am] Dated: September 12, 2013. Carolyn A. Baum, Program Officer, Office of Federal Advisory Committee Policy. BILLING CODE 4160–01–P [FR Doc. 2013–22631 Filed 9–17–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Center for Scientific Review Advisory Council. Date: October 28, 2013. Time: 8:00 a.m. to 4:00 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, Room 3091, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Donald L. Schneider, Ph.D., Senior Advisor to the Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3030, PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, ADD Health Renewal. Date: October 9, 2013. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\18SEN1.SGM 18SEN1

Agencies

[Federal Register Volume 78, Number 181 (Wednesday, September 18, 2013)]
[Notices]
[Page 57399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22631]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Center for Scientific Review Advisory Council.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Center for Scientific Review Advisory 
Council.
    Date: October 28, 2013.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: Provide advice to the Director, Center for Scientific 
Review (CSR), on matters related to planning, execution, conduct, 
support, review, evaluation, and receipt and referral of grant 
applications at CSR.
    Place: National Institutes of Health, Room 3091, 6701 Rockledge 
Drive, Bethesda, MD 20892.
    Contact Person: Donald L. Schneider, Ph.D., Senior Advisor to 
the Director, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 
20892, (301) 435-1111, schneidd@csr.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into NIH buildings. Visitors will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: https://public.csr.nih.gov/aboutcsr/CSROrganization/Pages/CSRAC.aspx, where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846- 93.878, 93.892, 
93.893, National Institutes of Health, HHS)

    Dated: September 12, 2013.
Carolyn A. Baum,
Program Officer, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-22631 Filed 9-17-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.